Experts are predictors, and many times they are on the wrong track. This year, there are virtually no experts, except Democratic Party mouthpieces, who are not predicting a Republican victory on November 2. Wisconsin, of course, is key because of three Congressional seats and one U.S. Senate seat that are in play.
Wisconsin Right to Life is not a partisan organization. However, it is no secret that, sadly, Democratic lawmakers have been leaving the right-to-life fold in droves over the past 30 years. A right-to-life Dem is a treasured rarity. Thus, a Republican tsunami, would benefit our great cause.
Gallup finds that Republicans lead Democrats in the generic poll by 10 points. POLITICO reports that Dems are running away from health care — touting their “no” vote but ignoring “yes” votes. Polls again show that the public deeply opposes Obamacare.
Many things can happen between now and November 2. And, being complacent is downright stupid. You won’t catch WRTL in the “stupid” camp.
Philip Nitschke is known throughout the world as one of the biggest proponents of assisted suicide and euthanasia. One of his pet projects is enticing older people to come to his workshops where they can learn all of the ways to kill themselves. His favorite weapon is what he calls the “peaceful pill.” Nitschke is proud to teach people how to make their own.
A promo for his workshops scheduled for Canada is as follows:
Exit Safe Suicide Meetings & Workshops
Nth America Tour 2010
Meetings & Workshops with Dr Philip Nitschke MD PhD
Public Meetings provide an outline of the legislative history & current political status of safe/ Assisted Suicide. These meetings are free & open events (11am - 12 noon).
Safe Suicide Workshops follow immediately from Public Meetings & provide the latest end of life information for Seniors, the Seriously Ill &
their Families based on the Peaceful Pill eHandbook updates on practical end of life issues (1 - 4pm).
Topics Covered
Includes the latest research on:
• The Barbiturates: Sources, Storage, Testing & the Ohio Single Drug Protocol
• Gases: Helium, Nitrogen, Argon - the physiology of hypoxia, flow rates & detection, the role of carbon dioxide
Most people believe, based on media hype, that embryonic stem cell research is already working to help or cure patients with conditions like Parkinson’s. The truth is that not a single human patient has even received, let alone been helped, by an embryonic stem cell.
Recently, the FDA granted permission to the Geron Corporation of California to begin human trials using embryonic stem cells for patients with blindness and spinal cord injuries. Even proponents of embryonic stem cell research worry publicly about whether the tests are coming too soon. According to an article in the Washington Post, “the tests are worrying many proponents: Some argue that the experiments are premature, others question whether they are ethical, and many fear that the trials risk disaster for the field if anything goes awry.”
The major obstacle causing the worry is that embryonic stem cells cause tumors when used in laboratory animals. That is no small problem.
“There’s going to be a perception that if the cells do not perform well, the entire field will be illegitimate,” says Evan Snyder, director of the stem cell program at the Sanford-Burnham Medical Research Institute in San Diego in the Post article.
Unphased, the Obama Administration has, as expected, filed an appeal of the ruling by a federal judge who struck down the President’s Executive Order allowing federal taxpayer dollars to be used for embryonic stem cell research. Congressional action may follow this fall.
![[Email]](http://www.wrtl.org/blog/wp-content/plugins/bookmarkify/email.png)
![[Facebook]](http://www.wrtl.org/blog/wp-content/plugins/bookmarkify/facebook.png)
![[MySpace]](http://www.wrtl.org/blog/wp-content/plugins/bookmarkify/myspace.png)
![[Twitter]](http://www.wrtl.org/blog/wp-content/plugins/bookmarkify/twitter.png)
